455 related articles for article (PubMed ID: 11858519)
21. Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology.
Hersh AM; Alomari S; Tyler BM
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35456971
[TBL] [Abstract][Full Text] [Related]
22. Polymeric nanoparticles for the drug delivery to the central nervous system.
Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
[TBL] [Abstract][Full Text] [Related]
23. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." The blood-brain barrier: a physical and conceptual challenge.
Hachinski V; Lee TY
Alzheimers Dement; 2009 Sep; 5(5):435-6. PubMed ID: 19751924
[No Abstract] [Full Text] [Related]
24. Recent progress of drug nanoformulations targeting to brain.
Khan AR; Yang X; Fu M; Zhai G
J Control Release; 2018 Dec; 291():37-64. PubMed ID: 30308256
[TBL] [Abstract][Full Text] [Related]
25. Commentary on "Alzheimer's disease drug development and the problem of the blood-brain barrier." Alzheimer's disease drugs: more than one barrier to breach.
Roher AE; Kokjohn TA
Alzheimers Dement; 2009 Sep; 5(5):437-8. PubMed ID: 19751925
[No Abstract] [Full Text] [Related]
26. Exploiting the properties of biomolecules for brain targeting of nanoparticulate systems.
Cramer S; Rempe R; Galla HJ
Curr Med Chem; 2012; 19(19):3163-87. PubMed ID: 22612701
[TBL] [Abstract][Full Text] [Related]
27. Nanoparticles as novel carrier for brain delivery: a review.
Agarwal A; Lariya N; Saraogi G; Dubey N; Agrawal H; Agrawal GP
Curr Pharm Des; 2009; 15(8):917-25. PubMed ID: 19275654
[TBL] [Abstract][Full Text] [Related]
28. Influence of the surface properties on nanoparticle-mediated transport of drugs to the brain.
Kreuter J
J Nanosci Nanotechnol; 2004 May; 4(5):484-8. PubMed ID: 15503433
[TBL] [Abstract][Full Text] [Related]
29. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
Garcia-Garcia E; Andrieux K; Gil S; Couvreur P
Int J Pharm; 2005 Jul; 298(2):274-92. PubMed ID: 15896933
[TBL] [Abstract][Full Text] [Related]
30. On the future development of optimally-sized lipid-insoluble systemic therapies for CNS solid tumors and other neuropathologies.
Sarin H
Recent Pat CNS Drug Discov; 2010 Nov; 5(3):239-52. PubMed ID: 20722627
[TBL] [Abstract][Full Text] [Related]
31. Recent advances in medicinal chemistry and pharmaceutical technology--strategies for drug delivery to the brain.
Denora N; Trapani A; Laquintana V; Lopedota A; Trapani G
Curr Top Med Chem; 2009; 9(2):182-96. PubMed ID: 19200004
[TBL] [Abstract][Full Text] [Related]
32. Transport Across the Blood-Brain Barrier.
Fu BM
Adv Exp Med Biol; 2018; 1097():235-259. PubMed ID: 30315549
[TBL] [Abstract][Full Text] [Related]
33. The blood-brain barrier choline transporter as a brain drug delivery vector.
Allen DD; Lockman PR
Life Sci; 2003 Aug; 73(13):1609-15. PubMed ID: 12875893
[TBL] [Abstract][Full Text] [Related]
34. Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases.
Saraiva C; Praça C; Ferreira R; Santos T; Ferreira L; Bernardino L
J Control Release; 2016 Aug; 235():34-47. PubMed ID: 27208862
[TBL] [Abstract][Full Text] [Related]
35. Alzheimer's disease drug development and the problem of the blood-brain barrier.
Pardridge WM
Alzheimers Dement; 2009 Sep; 5(5):427-32. PubMed ID: 19751922
[TBL] [Abstract][Full Text] [Related]
36. Drug delivery to brain by microparticulate systems.
Kaş HS
Adv Exp Med Biol; 2004; 553():221-30. PubMed ID: 15503459
[TBL] [Abstract][Full Text] [Related]
37. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
Kreuter J; Shamenkov D; Petrov V; Ramge P; Cychutek K; Koch-Brandt C; Alyautdin R
J Drug Target; 2002 Jun; 10(4):317-25. PubMed ID: 12164380
[TBL] [Abstract][Full Text] [Related]
38. Nanodelivery systems for overcoming limited transportation of therapeutic molecules through the blood-brain barrier.
Kim KT; Lee HS; Lee JJ; Park EK; Lee BS; Lee JY; Bae JS
Future Med Chem; 2018 Nov; 10(22):2659-2674. PubMed ID: 30499740
[TBL] [Abstract][Full Text] [Related]
39. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease.
Roney C; Kulkarni P; Arora V; Antich P; Bonte F; Wu A; Mallikarjuana NN; Manohar S; Liang HF; Kulkarni AR; Sung HW; Sairam M; Aminabhavi TM
J Control Release; 2005 Nov; 108(2-3):193-214. PubMed ID: 16246446
[TBL] [Abstract][Full Text] [Related]
40. A review of multifunctional nanoemulsion systems to overcome oral and CNS drug delivery barriers.
Ganta S; Deshpande D; Korde A; Amiji M
Mol Membr Biol; 2010 Oct; 27(7):260-73. PubMed ID: 20929336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
